Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients.

MLA

Catherinot, Emilie, et al. “Inhaled Therapies, Azithromycin and Mycobacterium Abscessus in Cystic Fibrosis Patients.” The European Respiratory Journal, vol. 41, no. 5, May 2013, pp. 1101–06. EBSCOhost, https://doi.org/10.1183/09031936.00065612.

APA

Catherinot, E., Roux, A.-L., Vibet, M.-A., Bellis, G., Lemonnier, L., Le Roux, E., Bernède-Bauduin, C., Le Bourgeois, M., Herrmann, J.-L., Guillemot, D., & Gaillard, J.-L. (2013). Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients. The European Respiratory Journal, 41(5), 1101–1106. https://doi.org/10.1183/09031936.00065612

Chicago

Catherinot, Emilie, Anne-Laure Roux, Marie-Anne Vibet, Gil Bellis, Lydie Lemonnier, Evelyne Le Roux, Claire Bernède-Bauduin, et al. 2013. “Inhaled Therapies, Azithromycin and Mycobacterium Abscessus in Cystic Fibrosis Patients.” The European Respiratory Journal 41 (5): 1101–6. doi:10.1183/09031936.00065612.